Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
348 INR | -0.47% | +1.89% | -15.09% |
Apr. 26 | Aster DM Healthcare Names CFO | MT |
Apr. 25 | Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 41.87 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.09% | 2.09B | - | ||
-18.52% | 16.6B | B+ | ||
+5.41% | 12.87B | B | ||
+3.98% | 11.78B | B+ | ||
+4.38% | 10.28B | B+ | ||
+28.07% | 8.6B | B | ||
-4.98% | 7.64B | A- | ||
+6.76% | 6.82B | B- | ||
+6.44% | 6.4B | D | ||
+48.17% | 4.58B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ASTERDM Stock
- Ratings Aster DM Healthcare Limited